Executive grant adds to Novonix (NVX) unquoted performance rights pool
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Novonix Limited reported the issue of 5,862,567 unquoted NVXAD performance rights on May 5, 2026 under an employee incentive scheme. These rights were issued to key management personnel member Michael O'Kronley and are not intended to be quoted on ASX.
After this grant, Novonix has 861,442,940 NVX ordinary fully paid shares on issue, 35,021,775 NVXAD performance rights, 14,016,667 NVXAA options and 45,221,586 NVXAL convertible notes outstanding. The issue relied on exception 13 in ASX Listing Rule 7.2, so did not require separate security holder approval.
Positive
- None.
Negative
- None.
Key Figures
New performance rights issued: 5,862,567 NVXAD performance rights
Ordinary shares on issue: 861,442,940 NVX ordinary shares
Total performance rights outstanding: 35,021,775 NVXAD performance rights
+2 more
5 metrics
New performance rights issued
5,862,567 NVXAD performance rights
Issued May 5, 2026 under employee incentive scheme
Ordinary shares on issue
861,442,940 NVX ordinary shares
Quoted fully paid shares on ASX after the grant
Total performance rights outstanding
35,021,775 NVXAD performance rights
Unquoted securities on issue after new grant
Options outstanding
14,016,667 NVXAA options
Unquoted, expiring on various dates at various prices
Convertible notes outstanding
45,221,586 NVXAL convertible notes
Unquoted securities on issue
Key Terms
+employee incentive scheme, PERFORMANCE RIGHTS, key management personnel (KMP), convertible notes, +1 more
5 terms
+employee incentive scheme financial
"The +securities the subject of this notification are +Other securities issued under an +employee incentive scheme"
PERFORMANCE RIGHTS financial
"NVXAD | PERFORMANCE RIGHTS | 5,862,567 | 5/05/2026"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
key management personnel (KMP) financial
"Were any of the +securities issued to +key management personnel (KMP) or an +associate?"
convertible notes financial
"NVXAL CONVERTIBLE NOTES | 45,221,586"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
Listing Rule 7.2 financial
"Were the +securities issued under an exception in Listing Rule 7.2"
FAQ
What did Novonix (NVX) disclose in this Form 6-K and Appendix 3G?
Novonix disclosed the issue of 5,862,567 NVXAD performance rights on May 5, 2026 under an employee incentive scheme. These securities are unquoted on ASX and were issued to key management personnel, expanding the company’s existing pool of performance rights.
How many performance rights did Novonix (NVX) grant and to whom?
Novonix granted 5,862,567 NVXAD performance rights to key management personnel member Michael O'Kronley. The rights were issued under an employee incentive scheme and are part of an existing class of unquoted securities that are not intended to be quoted on the ASX.
What unquoted securities does Novonix (NVX) have on issue after this transaction?
After the transaction, Novonix has 35,021,775 NVXAD performance rights, 14,016,667 NVXAA options expiring on various dates at various prices, and 45,221,586 NVXAL convertible notes. These classes are unquoted on ASX and form part of the company’s broader capital base.
Are the new Novonix (NVX) performance rights intended to trade on the ASX?
The new NVXAD performance rights are not intended to be quoted on ASX. They are described as other securities issued under an employee incentive scheme, forming part of an unquoted class that ranks equally with existing performance rights in that class from the issue date.
